Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s growth are falling, too.
Category: Novo Nordisk A/S
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
